I believe contingency plan but this may be wrong so let me know! Thanks
Answer:
Option 1 PV lumpsum = $200000
Option2 PV of Annuity = $195413.08035 rounded off to $195413.08
Based on the present value of both the options, Option 1 should be chosen as it has a higher present value than option 2.
Explanation:
To decide on the best option to choose among the given two, we need to find the present value of both the options.
As the first option is to receive a lumpsum payment of $200000 today, the present value of this option is also equal to $200000 as it will be received today.
Option two, on the other hand, is an annuity as fixed payments will be received after equal intervals of time and for a limited time period and at the end of the period which satisfies the criteria of annuity ordinary. We will use the formula for the present value of annuity which is,
PV of Annuity = C * [( 1 - (1+r)^-n) / r]
Where,
- C is the periodic payment
- r is the rate of return of discount rate
- n is the number of periods
The periodic payment is provided as $1400. We are also provided with and APR of 6% which is the Annual rate. We will have to convert it into monthly rate by dividing it by 12. We are also provided with the number of years which we will need to convert into number of months by multiplying it by 12.
Monthly r = 6%/12 = 0.5%
Number of periods = 20 * 12 = 240
PV of Annuity = 1400 * [( 1 - (1+0.5%)^-240) / 0.5%]
PV of Annuity = $195413.08035 rounded off to $195413.08
Answer: Test the solution
Explanation:
Since the user called and said that she can no longer access the network after she steeped on the network cable, and another cable was made and attached from the wall plate to the user's computer, the next thing that should be done is to test the solution.
The solution should be tested in order to be sure that the solution that was provided worked. After this has been done, then documenting he solution and recognizing the effects can be done.
Answer;
<span>if investigators are complying with ICH E6 guideline, they must clearly disclose to subjects in the informed consent form that the monitor, auditor, IRB/IEC, and the regulatory authorities may have access to the subject's medical records.
Explanation;
</span>The FDA regulations allow subjects or the legally acceptable representatives to receive either a signed or unsigned copy. Therefore, they must obtain the informed consent of the subject which grant them direct access to the subject's original medical records for verification of medical trial procedure and/ or data without violating the confidentiality of the subject to the extent permitted by relevant law and regulations
